Beneficient Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Net Income -$69.4M-235.6% YoYTTM through 30 Jun 2026
Free Cash Flow -$32MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 21.1% |
| Net Margin | 106.7% |
Returns
116.1%ROE
-44.2%ROA
Balance Sheet Health
Debt / Equity-0.78x
Net Debt$92.4M
Cash & Equivalents$5.6M
Quality Metrics
Piotroski F-Score2 / 9
FCF Margin223.1%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2026: -$39.1M
Diluted EPSFY2023: $-1.94
Dividend
No dividend
Capital Allocation
Capex Intensity0.0%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Ben Liquidity | $8.2M | ||
| Ben Custody | $2.9M |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.